National Heart, Lung, and Blood Institute; Notice of Closed Meetings, 75260-75261 [06-9703]

Download as PDF 75260 Federal Register / Vol. 71, No. 240 / Thursday, December 14, 2006 / Notices rwilkins on PROD1PC63 with NOTICES Development Status: Animal data is available. Inventors: Triantafyllos Chavakis (NCI) et al. Publications: (1) T Chavakis et al. Staphylococcus aureus extracellular adherence protein serves as anti-inflammatory by inhibiting the recruitment of host leukocytes. Nat Med. 2002 Jul;8(7):687– 693. (2) C Xie et al. Suppression of experimental autoimmune encephalomyelitis by extracellular adherence protein of Staphylococcus aureus. J Exp Med. 2006 Apr 17;203(4):985–994. Patent Status: U.S. Provisional Application No. 60/771,884 filed 10 Feb 2006 (HHS Reference No. E–295–2005/ 0–US–01). Availability: Available for exclusive and non-exclusive licensing. Licensing Contact: Norbert Pontzer, Ph.D., J.D.; 301/435–5502; pontzern@mail.nih.gov. Collaborative Research Opportunity: The National Cancer Institute Experimental Immunology Branch is seeking statements of capability or interest from parties interested in collaborative research to further develop, evaluate, or commercialize Novel Treatments for Autoimmune Neuroinflammatory Diseases including Multiple Sclerosis. Please contact Betty Tong, Ph.D. at 301–594–4263 for more information. Gene Cassette for Enhancement of Protein Production Description of Technology: There is a continuing market need for expression systems that improve recombinant protein production for disease therapeutics or research materials. The present invention describes a ‘‘gene cassette’’ containing the aadA1 (aminoglycoside adenylyltransferase) gene that increases protein expression levels when incorporated into a bacterial or eukaryotic host genome. In bacterial systems, the inventors have shown that this gene cassette induces enhancement of protein production and accumulation. This inducement is not restricted by the nature of the vector, induction system or nature of protein. In particular, this invention has yielded 3fold upregulation of anti-HIV peptide expression levels in a microbial microbicide (see reference below). This technology offers an effective mechanism for increased product yield that can be utilized for pharmaceutical or biotechnological applications. Applications: (1) Affordable gene cassette that increases production of recombinant or native proteins with VerDate Aug<31>2005 17:54 Dec 13, 2006 Jkt 211000 reduced culture volume and faster processing time; (2) Increases efficacy and potency of cell-based therapeutics that overexpress endogenous or heterologous proteins. Market: (1) Producers of protein, peptide, or cell-based therapeutics who would benefit from enhanced protein expression; (2) Researchers worldwide who utilize expression systems for protein synthesis. Development Status: System validated in bacterial cells. Development underway for use in eukaryotic expression systems. Inventors: Shankar Adhya and Sudeshna Kar (NCI). Publication: S Rao, S Hu, L McHugh, K Lueders, K Henry, Q Zhao, RA Fekete, S Kar, S Adhya, DH Hamer. Toward a live microbial microbicide for HIV: commensal bacteria secreting an HIV fusion inhibitor peptide. Proc Natl Acad Sci U S A. 2005 Aug 23;102(34):11993– 8. Epub 2005 Jul 22, doi 10.1073/ pnas.0504881102. Patent Status: U.S. Provisional Application No. 60/571,943 filed 18 May 2004 (HHS Reference No. E–261– 2003/0–US–01); PCT Application No. PCT/US2005/17001 filed 17 May 2005, which published as WO 2005/116222 on 08 Dec 2005 (HHS Reference No. E– 261–2003/0–PCT–02). Licensing Status: Available for exclusive or non-exclusive licensing. Licensing Contact: Tara L. Kirby, Ph.D.; 301/435–4426; tarak@mail.nih.gov. Dated: December 6, 2006. Steven M. Ferguson, Director, Division of Technology Development and Transfer, Office of Technology Transfer, National Institutes of Health. [FR Doc. E6–21301 Filed 12–13–06; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Cancer Institute; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C. as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, Frm 00034 Fmt 4703 Sfmt 4703 Name of Committee: National Cancer Institute Special Emphasis Panel, Molecular Biology Special Emphasis Panel. Date: January 29–31, 2007. Time: 6 p.m. to 3 p.m. Agenda: To review and evaluate grant applications. Place: Marriott Conference Center, 5701 Marinelli Road, Bethesda, MD 20852. Contact Person: Michael B Small, PhD, Scientific Review Administrator, Research Programs Review Branch, Division of Extramural Activities, National Cancer Institute, National Institutes of Health, 6116 Executive Blvd., Room 8127, Bethesda, MD 20892–8328, 301–402–0996, smallm@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel, Clinical Studies Special Emphasis Panel. Date: January 31–February 2, 2007. Time: 6 p.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Marriott Bethesda North Hotel and Conference Ctr., 5701 Marinelli Road, North Bethesda, MD 20852. Contact Person: Majed M Hamawy, PhD, Scientific Review Administrator, Research Programs Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 6116 Executive Boulevard, Room 8133, Bethesda, MD 20852. 301–594– 5659. mh101v@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS) Dated: December 6, 2006. Anna Snouffer, Acting Director, Office of Federal Advisory Committee Policy. [FR Doc. 06–9696 Filed 12–13–06; 8:45 am] BILLING CODE 4140–01–M National Institutes of Health PO 00000 and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Heart, Lung, and Blood Institute; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections E:\FR\FM\14DEN1.SGM 14DEN1 Federal Register / Vol. 71, No. 240 / Thursday, December 14, 2006 / Notices 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Heart, Lung, and Blood Institute Special Emphasis Panel, Genetics Research Project. Date: February 20, 2007. Time: 3 p.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892. (Telephone Conference Call). Contact Person: Mark Roltsch, PhD, Scientific Review Administrator, Review Branch, NHLBI, National Institutes of Health, 6701 Rockledge Drive, Room 7192, Bethesda, MD 20892, (301) 435–0285. roltschm@mail.nih.gov. Name of Committee: National Heart, Lung, and Blood Institute Special Emphasis Panel, Clinical Investigator and Research Scientist Development Awards (KO2 & KO8’s). Date: February 22–23, 2007. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Sheraton Crystal City Hotel, 1800 Jefferson Davis Highway, Arlington, VA 22202. Contact Person: Rina Das, PhD, Scientific Review Administrator, Review Branch, NHLBI, National Institutes of Health, 6701 Rockledge Drive, Room 7200, Bethesda, MD 20892, (301) 435–0297, dasr2@nhibi.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.233, National Center for Sleep Disorders Research; 93.837, Heart and Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, Blood Diseases and Resources Research, National Institutes of Health, HHS) Dated: December 8, 2006. Anna Snouffer, Acting Director, Office of Federal Advisory Committee Policy. [FR Doc. 06–9703 Filed 12–13–06; 8:45am] The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Child Health and Human Development Special Emphasis Panel, Prenatal Virally Induced Brain Disorder in Mouse. Date: December 14, 2006. Time: 1 p.m. to 2:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6100 Executive Boulevard, Room 5B01, Rockville, MD 20852 (Telephone Conference Call). Contact Person: Norman Chang, PhD, Scientific Review Administrator, Division of Scientific Review, National Institute of Child Health and Human Development, NIH, 6100 Executive Blvd., Room 5B01, Bethesda, MD 20892. (301) 496–1485. changn@mail.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. (Catalogue of Federal Domestic Assistance Program Nos. 93.864, Population Research; 93.865, Research for Mothers and Children; 93.929, Center for Medical Rehabilitation Research; 93.209, Contraception and Infertility Loan Repayment Program, National Institutes of Health, HHS) Dated: December 6, 2006. Anna Snouffer, Acting Director, Office of Federal Advisory Committee Policy. [FR Doc. 06–9695 Filed 12–13–06; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health BILLING CODE 4140–01–M National Institute on Alcohol Abuse and Alcoholism; Notice of Closed Meeting DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health rwilkins on PROD1PC63 with NOTICES National Institute of Child Health and Human Development; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting. VerDate Aug<31>2005 17:54 Dec 13, 2006 Jkt 211000 Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial PO 00000 Frm 00035 Fmt 4703 Sfmt 4703 75261 property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute on Alcohol Abuse and Alcoholism Initial Review Group, Health Services and Behavioral Research Review Subcommittee. Date: March 28–29, 2007. Time: 8:30 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Doubletree Hotel & Executive Meeting Center, 8120 Wisconsin Ave., Bethesda, MD 20814. Contact Person: Lorraine Gunzerath, PhD, MBA, Scientific Review Administrator, National Institute on Alcohol Abuse and Alcoholism, Office of Extramural Activities, Extramural Project Review Branch, 5635 Fishers Lane, Room 3043, Bethesda, MD 20892–9304, 301–443–2369, Igunzera@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.271, Alcohol Research Career Development Awards for Scientists and Clinicians; 93.272, Alcohol National Research Service Awards for Research Training; 93.273, Alcohol Research Programs; 93.891, Alcohol Research Center Grants, National Institutes of Health, HHS) Dated: December 6, 2006. Anna Snouffer, Acting Director, Office of Federal Advisory Committee Policy. [FR Doc. 06–9697 Filed 12–13–06; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute on Alcohol Abuse and Alcoholism; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institutes on Alcohol Abuse and Alcoholism Initial E:\FR\FM\14DEN1.SGM 14DEN1

Agencies

[Federal Register Volume 71, Number 240 (Thursday, December 14, 2006)]
[Notices]
[Pages 75260-75261]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 06-]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Heart, Lung, and Blood Institute; Notice of Closed 
Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections

[[Page 75261]]

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant 
applications and the discussions could disclose confidential trade 
secrets or commercial property such as patentable material, and 
personal information concerning individuals associated with the grant 
applications, the disclosure of which would constitute a clearly 
unwarranted invasion of personal privacy.

    Name of Committee: National Heart, Lung, and Blood Institute 
Special Emphasis Panel, Genetics Research Project.
    Date: February 20, 2007.
    Time: 3 p.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892. (Telephone Conference Call).
    Contact Person: Mark Roltsch, PhD, Scientific Review 
Administrator, Review Branch, NHLBI, National Institutes of Health, 
6701 Rockledge Drive, Room 7192, Bethesda, MD 20892, (301) 435-0285. 
roltschm@mail.nih.gov.

    Name of Committee: National Heart, Lung, and Blood Institute 
Special Emphasis Panel, Clinical Investigator and Research Scientist 
Development Awards (KO2 & KO8's).
    Date: February 22-23, 2007.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Sheraton Crystal City Hotel, 1800 Jefferson Davis 
Highway, Arlington, VA 22202.
    Contact Person: Rina Das, PhD, Scientific Review Administrator, 
Review Branch, NHLBI, National Institutes of Health, 6701 Rockledge 
Drive, Room 7200, Bethesda, MD 20892, (301) 435-0297, 
dasr2@nhibi.nih.gov.


(Catalogue of Federal Domestic Assistance Program Nos. 93.233, 
National Center for Sleep Disorders Research; 93.837, Heart and 
Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, 
Blood Diseases and Resources Research, National Institutes of 
Health, HHS)
    Dated: December 8, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 06-9703 Filed 12-13-06; 8:45am]
BILLING CODE 4140-01-M

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.